 Universities and government agencies have recognized the tremendous potential Protandim has in helping the body deal with a wide variety of diseases. Studies published so far include:
Protandim reduces oxidative stress
Published in Free Radical Biology and Medicine
study performed by University of Colorado
View the study.
Protandim increases Glutathione levels 300%
Published in Free Radical Biology and Medicine
study performed by University of Colorado
View the study.
Protandim reduced skin cancer incidence in mice
published in PloS ONE, an international, peer-reviewed, open access journal published by the Public Library of Science
study performed by Louisiana State University (LSU) and sponsored by the Skin Cancer Foundation ss
View the sudy.
Protandim provided heart protective effects, helps signal cell DNA to produce more antioxidants, anti-inflammatory, and anti-fibrotic genes
published in Circulation, journal of the American Heart Association
study performed by Virginia Commonwealth University
View the study.
Protandim reduces oxidative stress and fibrosis in mice with Duchenne's Muscular Dystrophy
published in the Journal of Dietary Supplements
study performed by Massachusetts General Hospital, Harvard Medical School, and the University of Colorado Denver, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases
View the study.
Further study into Protandim's chemoprotective effects
published in PloS ONE
study performed by Louisiana State University
View the study.
Protandim helps prevent blood vessel blockage in heart surgery patients
published in the Journal of Free Radical Biology and Medicine
study performed by Ohio State University sponsored by the American Heart Association and the National Institutes of Health
View the study.
|
Universities and institutions conducting research include:
- University of Colorado
- Colorado State University
- University of Utah
- Northwestern University
- Duke University
- Louisiana State University
- Ohio State University
- Vanderbilt University
- Glamorgan University, Wales
- Sahlgrenska University Hospital, Sweden
- Harvard University
- Mexican Institute of Social Security, Mexico City.
Conditions being studied include:
- altitude sickness
- non-alcoholic steatohepatitis
- lung antioxidant status in withdrawing alcoholics
- autonomic physiology and aging
- skin cancer
- multiple sclerosis
- pulmonary hypertension
- heart disease
- coronary artery bypass graft failure
- asthma
- Duchenne muscular dystrophy
- hearing loss
|
